Recruiting

Aflibercept

Sponsor:

Southeast Retina Center, Georgia

Code:

NCT02092532

Conditions

Neovascular Polypoidal Choroidal Vasculopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Rescue Intravitreal Aflibercept Injection

Rescue Therapy with PDT, Laser or Intravitreal Steroids

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Southeast Retina Center, Georgia on 2014-10-15.